Almac Group

Almac Group is a biotechnology, health care, and pharmaceutical company that was founded in 2002 and is headquartered in the United Kingdom. The company’s slogan, "A unique culture delivering exceptional solutions," reflects its commitment to advancing human health through its wide range of services. With a workforce of 7,000 employees globally, Almac has gained the trust of 600+ companies worldwide, including market leaders, over the past 50 years. The recent $1.00M grant investment on December 4, 2019 from the Bill & Melinda Gates Foundation further validates the quality, innovation, and efficiency of the company's business. Almac's services encompass various aspects of the pharmaceutical industry, including biomarker discovery & development, API services & chemical development, pharmaceutical development, analytical services, clinical trial supply, clinical technologies, and commercial services. This extensive range of offerings positions Almac as a comprehensive and reliable partner for companies seeking support in drug development and commercialization. The company's robust presence in the industry, demonstrated by its partnerships and investments, as well as its persistent commitment to exceptional solutions, underscores Almac Group's potential for sustained growth and impact in the biotechnology and pharmaceutical sectors. For those interested in contributing to this impactful journey, Almac provides exceptional career opportunities, inviting individuals to join its talent network for further engagement.